Citations

Showing 10 of 108162 citations.

Family Visitation Policies in the ICU and Delirium
Wilson, Michael E. , Bauer, Philippe R. , Rabinstein, Alejandro A.

Mayo Clinic

JAMA | November 19, 2019 | Volume: 322 | Issue: 19 | Pages: 1923

10.1001/jama.2019.15585 | PMID 31742625 Get It

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
Lu, Kaifeng , Finnegan, Michelle , Szegedi, Armin, Trugman, Joel M. , Lipton, Richard B. , Dodick, David W. , Ailani, Jessica

Mayo Clinic

JAMA | November 19, 2019 | Volume: 322 | Issue: 19 | Pages: 1887

10.1001/jama.2019.16711 | PMID 31742631 Get It

Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation
Zhao, Yanjun , Seelhammer, Troy G. , Frazee, Erin N. , Wilson, John , Frazee, Erin N

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | November 19, 2019 | Volume: 40 | Issue: 1 | Pages: 89-95

10.1002/phar.2348 | PMID 31742741 Get It

Drug pharmacokinetics may be significantly altered in patients receiving extracorporeal membrane oxygenation (ECMO). Ensuring the optimized effective dosing of antimicrobials on ECMO remains a challenge. To date, limited data are available regarding the optimal use of amphotericin and triazoles during ECMO. We report a case of altered pharmacokinetics, insufficient liposomal amphotericin B and isavuconazole levels, and the need for escalated doses during ECMO in a patient with severe acute respiratory distress syndrome secondary to pulmonary blastomycosis. A 2‐fold increase in the standard total daily dose of both drugs was necessary to overcome low serum concentrations thought to be secondary to drug loss from ECMO circuit sequestration. These findings have important implications for optimizing antimicrobial therapy in patients receiving ECMO to maximize therapeutic efficacy. The use of therapeutic drug monitoring for patients receiving antimicrobial therapy with concurrent ECMO may facilitate appropriate drug dosing to achieve adequate serum concentrations and optimize favorable patient outcomes. Further studies exploring antimicrobial pharmacokinetics during ECMO are needed to inform dosing recommendations in critically ill patients.
The Value of Interracial Contact for Reducing Anti-Black Bias Among Non-Black Physicians: A Cognitive Habits and Growth Evaluation (CHANGE) Study Report
Onyeador, Ivuoma N. , Wittlin, Natalie M. , Burke, Sara E. , Dovidio, John F. , Perry, Sylvia , Ryn, Michelle van , Dyrbye, Liselotte N. , Phelan, Sean M. , Perry, Sylvia P , van Ryn, Michelle , Hardeman, Rachel R. , Herrin, Jeph

Mayo Clinic

Psychological Science | November 19, 2019 | Volume: 31 | Issue: 1 | Pages: 18-30

10.1177/0956797619879139 | PMID 31743078 Get It

Although scholars have long studied circumstances that shape prejudice, inquiry into factors associated with long-term prejudice reduction has been more limited. Using a 6-year longitudinal study of non-Black physicians in training ( N = 3,134), we examined the effect of three medical-school factors—interracial contact, medical-school environment, and diversity training—on explicit and implicit racial bias measured during medical residency. When accounting for all three factors, previous contact, and baseline bias, we found that quality of contact continued to predict lower explicit and implicit bias, although the effects were very small. Racial climate, modeling of bias, and hours of diversity training in medical school were not consistently related to less explicit or implicit bias during residency. These results highlight the benefits of interracial contact during an impactful experience such as medical school. Ultimately, professional institutions can play a role in reducing anti-Black bias by encouraging more frequent, and especially more favorable, interracial contact.
Preadmission Antiplatelet Use and Associated Outcomes and Costs Among ICU Patients With Intracranial Hemorrhage
Mok, Garrick , English, Shane , Thavorn, Kednapa , McCredie, Victoria , Dowlatshahi, Dar , Perry, Jeffrey J. , Kyeremanteng, Kwadwo , Fernando, Shannon M. , Rochwerg, Bram , Wijdicks, Eelco F. M. , Reardon, Peter M. , Tanuseputro, Peter , Kyeremanteng, Kwadwo

Mayo Clinic

Journal of Intensive Care Medicine | November 19, 2019 | Volume: 36 | Issue: 1 | Pages: 70-79

10.1177/0885066619885347 | PMID 31741418 Get It

Introduction: Patients with intracranial hemorrhage (including intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic hemorrhage) are commonly admitted to the intensive care unit (ICU). Although indications for oral antiplatelet agents are increasing, the impact of preadmission use on outcomes in patients with intracranial hemorrhage admitted to the ICU is unknown. We sought to evaluate the association between preadmission oral antiplatelet use, in-hospital mortality, resource utilization, and costs among ICU patients with intracranial hemorrhage. Methods: We retrospectively analyzed a prospectively collected registry (2011-2016) and included consecutive adult patients from 2 hospitals admitted to ICU with intracranial hemorrhage. Patients were categorized on the basis of preadmission oral antiplatelet use. We excluded patients with preadmission anticoagulant use. The primary outcome was in-hospital mortality and was analyzed using a multivariable logistic regression model. Contributors to total hospital cost were analyzed using a generalized linear model with log link and gamma distribution. Results: Of 720 included patients with intracranial hemorrhage, 107 (14.9%) had been using an oral antiplatelet agent at the time of ICU admission. Oral antiplatelet use was not associated with in-hospital mortality (adjusted odds ratio: 1.31 [95% confidence interval [CI]: 0.93-2.22]). Evaluation of total costs also revealed no association with oral antiplatelet use (adjusted ratio of means [aROM]: 0.92 [95% CI: 0.82-1.02, P = .10]). Total cost among patients with intracranial hemorrhage was driven by illness severity (aROM: 1.96 [95% CI: 1.94-1.98], P < .001), increasing ICU length of stay (aROM: 1.05 [95% CI: 1.05-1.06], P < .001), and use of invasive mechanical ventilation (aROM: 1.76 [95% CI: 1.68-1.86], P < .001). Conclusions: Among ICU patients admitted with intracranial hemorrhage, preadmission oral antiplatelet use was not associated with increased in-hospital mortality or hospital costs. These findings have important prognostic implications for clinicians who care for patients with intracranial hemorrhage.
Letter: Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas
Hopewell, J. W. , Klinge, Thomas , Graffeo, Christopher S. , Pollock, Bruce E. , Sneed, Penny K. , Paddick, Ian

Mayo Clinic

Neurosurgery | November 19, 2019 | Volume: 86 | Issue: 4 | Pages: E407-E409

10.1093/neuros/nyz547 | PMID 31832671 Get It

Total Elbow Arthroplasty: Clinical Outcomes, Complications, and Revision Surgery
Koh, Kyoung‐Hwan, Jeon, In‐Ho , Kwak, Jae-Man, Kwak, Jae‐Man , Koh, Kyoung Hwan

Mayo Clinic

Clinics in Orthopedic Surgery | November 19, 2019 | Volume: 11 | Issue: 4 | Pages: 369

10.4055/cios.2019.11.4.369 | PMID 31788158 Get It

Implementing a Liver Contrast Program in the Sonography Laboratory
Bagley, Jennifer , Hunt, Talisha M. , Paul, Dennis E.

Mayo Clinic

Journal of Diagnostic Medical Sonography | November 19, 2019 | Volume: 36 | Issue: 1 | Pages: 80-90

10.1177/8756479319889612 Get It

In inpatients with community-acquired pneumonia, a bundled intervention with steroids did not reduce length of stay
Moraes, Alice Gallo de , O’Horo, John C.

Mayo Clinic

Annals of Internal Medicine | November 18, 2019 | Volume: 171 | Issue: 10 | Pages: JC52

10.7326/acpj201911190-052 | PMID 31739335 Get It